Risk-free orders: 60-day money-back guarantee

The science, read before buying

Growth, explained.

MK-677, ibutamoren, is an oral ghrelin-receptor agonist: a growth hormone secretagogue studied in 25+ human trials since 1995. It does not add a synthetic hormone. In research, it signals the pituitary to amplify the GH pulses the body already produces. The mechanism, the numbers, and every citation are below.

Class

GH secretagogue

Ghrelin-receptor agonist (GHS-R1a)

Route

Oral

No injections, no reconstitution

Half-life

~24 h

One serving covers the full day

Human trials

25+

1995 to present, incl. a 2-year RCT

Rendered molecular structure of Ibutamoren MK-677 against a dark background
Fig. 01, Ibutamoren (MK-677), free baseC27H36N4O5S · 528.7 g/mol

The mechanism

It doesn't add GH. It asks for more.

No synthetic hormone enters the body. In research, MK-677 works upstream, on the release signal itself. Four steps, all inside the natural feedback loop.

  1. 1

    Binds the ghrelin receptor

    MK-677 is an oral ghrelin mimetic. It docks into the GHS-R1a receptor, the same switch the body uses to trigger growth hormone release.

  2. 2

    The pituitary amplifies its GH pulses

    The pituitary responds with stronger, natural GH pulses. No synthetic hormone enters the body: its own output is simply turned up.

  3. 3

    IGF-1 climbs for 24 hours

    The liver converts elevated GH into IGF-1, the primary growth and repair signal. A ~24-hour half-life means one serving covers the full day.

  4. 4

    The natural axis stays intact

    Signaling stays inside the body's own feedback loop. Research shows MK-677 does not act on the testosterone axis, so there is nothing to restore afterward.

The numbers

Measured, not promised.

Every figure below comes from a published human trial, polysomnography, blood panels, whole-body composition analysis. The citation is on the card.

+50%

Stage IV deep sleep

REM sleep +20% in the same trial. Recorded with polysomnography in healthy young adults.

Copinschi et al., Neuroendocrinology, 1997

+88%

IGF-1 at 4 weeks

+55% within the first 2 weeks at 25 mg daily. IGF-1 is the primary growth signal GH produces.

Chapman et al., JCEM, 1996

+3 kg

Fat-free mass in 8 weeks

Versus placebo, without a training program. Recorded by whole-body composition analysis.

Murphy et al., JCEM, 1998

2 yrs

Sustained elevation

GH and IGF-1 restored to young-adult range and held there. No desensitization observed.

Nass et al., Annals of Internal Medicine, 2008

Reference index

Don't take our word. Take the journals'.

The four trials behind the numbers above. We didn't write these results, the journals did.

  • Ref 01chapman-1996

    IGF-1 +55% in 2 weeks, +88% at 4 weeks (25 mg daily)

    Chapman IM, et al. Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly adults. J Clin Endocrinol Metab, 1996.

  • Ref 02murphy-1998

    +3 kg fat-free mass in 8 weeks vs placebo

    Murphy MG, et al. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism. J Clin Endocrinol Metab, 1998.

  • Ref 03copinschi-1997

    Stage IV deep sleep +50%, REM sleep +20%

    Copinschi G, et al. Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man. Neuroendocrinology, 1997.

  • Ref 04nass-2008

    GH & IGF-1 restored to young-adult range, sustained 2 years, no desensitization

    Nass R, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Annals of Internal Medicine, 2008.

4 of 25+ human trials selected · Full texts indexed on PubMed, journal and year in every citation.

Full disclosure

What we won't hide from you

Most product pages stop at the good news. Ours doesn't, the candor is deliberate. If we're straight about the downsides, the purity number means more.

What we won't hide
  • Appetite increase is real, especially weeks 1-2. It's the mechanism, not a flaw.

  • Expect 2-5 lbs of transient water retention in the first month.

  • Fasting glucose can drift up. If you manage blood-sugar or insulin issues, talk to your physician first.

  • No Phase III trials exist. Long-term safety beyond 2 years hasn't been established.

  • Effects reverse 2-4 weeks after stopping. Training and food are still required.

Disclosed up front, the same standard we apply to the purity number.

Expectations

An honest timeline

What trial data and buyer reports actually show, phase by phase. Trials ran 8 weeks and longer, that's why the guarantee is 60 days, not 14.

  • Days 1-5

    Appetite arrives first

    It's a ghrelin mimetic: hunger is the mechanism working. Peaks in the first two weeks, then normalizes. Bulkers call this a feature.

  • Weeks 1-2

    Sleep depth changes

    The most consistently reported early effect: heavier, fuller sleep as nocturnal GH pulses amplify. Trials recorded +50% stage-IV sleep.

  • Weeks 2-4

    Water retention (transient)

    2-5 lbs of temporary water is common in research and community reports as IGF-1 rises. It settles. We tell you because nobody else does.

  • Weeks 6-8

    Fullness & recovery

    Improved nitrogen retention and glycogen storage read as fuller muscles, better pumps, and faster bounce-back between sessions.

  • Months 3-6

    Body-composition changes

    Where trials recorded fat-free mass differences vs placebo. Training and food are still required. This amplifies work, it doesn't replace it.

Next step

The research is public. So is our lab report.

120 capsules, 60 days, $34.95, $0.58/day. Batch #1213681 verified at 99.635% purity, and every order is covered by the 60-day empty-bottle guarantee.